Nautilus Biotechnology, Inc.
NAUT
$0.89
$0.16723.10%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 2.11% | 5.06% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.69% | 4.61% | |||
| Operating Income | 5.69% | -4.61% | |||
| Income Before Tax | 5.58% | -6.98% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 5.58% | -6.98% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 5.58% | -6.98% | |||
| EBIT | 5.69% | -4.61% | |||
| EBITDA | 5.98% | -5.18% | |||
| EPS Basic | 5.86% | -6.71% | |||
| Normalized Basic EPS | 18.76% | -23.69% | |||
| EPS Diluted | 5.86% | -6.71% | |||
| Normalized Diluted EPS | 18.76% | -23.69% | |||
| Average Basic Shares Outstanding | 0.28% | 0.27% | |||
| Average Diluted Shares Outstanding | 0.28% | 0.27% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||